[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-341341-105":59,"doc-detail-341341-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","recent-advances-in-understanding-the-immune-microenvironment-in-ovarian-cancer-review","Recent advances in understanding the immune microenvironment in ovarian cancer - Review","","Ovarian cancer remains a leading cause of women’s cancer mortality, and although treatment has advanced, patient outcomes are still unsatisfactory, particularly due to recurrence and limited effectiveness of current immunotherapeutic strategies. This review analyzes how the ovarian cancer tumor microenvironment shapes tumor growth and immune regulation, focusing on distinct cellular components and their signaling mechanisms. It also discusses immunotherapy rechallenge, emphasizing the biological basis of resistance to immune checkpoint inhibitor therapy and the implications for future research.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/recent-advances-in-understanding-the-immune-microenvironment-in-ovarian-cancer-review/341341/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/recent-advances-in-understanding-the-immune-microenvironment-in-ovarian-cancer-review/341341.png","ImageObject",300,407,{"name":92,"@type":93},"Aria","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-04","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why is the immune microenvironment important in ovarian cancer?","Question",{"text":112,"@type":113},"The tumor microenvironment can initially suppress tumor growth but later shifts to promote tumor progression. Immune cells within this microenvironment are therefore key targets for immunotherapy.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does immune checkpoint inhibitor therapy relate to the tumor microenvironment?",{"text":117,"@type":113},"Immune checkpoint inhibitors have the potential to regulate the tumor microenvironment by suppressing pro-tumor factors, reactivating immune cells, managing tumor growth, and extending survival in advanced cancer.",{"name":119,"@type":110,"acceptedAnswer":120},"What does the review cover regarding immunotherapy rechallenge?",{"text":121,"@type":113},"The review examines immunotherapy rechallenge in ovarian cancer, with emphasis on the biological reasons underlying resistance to immune checkpoint inhibitors.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},341341,1790240617,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},2336464648322,"https://ap-avatar.wpscdn.com/avatar/2200025388227c56fec?_k=1778556882303663488","TYPE Review  \nPUBLISHED 05 June 2024  \nDOI 10.3389/fimmu.2024.1412328  \nOPEN ACCESS  \nEDITED BY  \nDechao Feng,  \nUniversity College London, United Kingdom  \nREVIEWED BY  \nSadhna Aggarwal,  \nUniversity of Texas MD Anderson Cancer Center, United States  \nAnm Nazmul Hasan Khan, University at Buffalo, United States LianCheng Zhu,  \nChina Medical University, China  \n*CORRESPONDENCE Yiming Ma  \n [reiner0666@163.com](reiner0666@163.com)[ ](reiner0666@163.com)Ye Zhang  \n [eagleelena@163.com](eagleelena@163.com)  \nRECEIVED 04 April 2024  \nACCEPTED 22 May 2024  \nPUBLISHED 05 June 2024  \nCITATION  \nChen J, Yang L, Ma Y and Zhang Y (2024) Recent advances in understanding the immune microenvironment in ovarian cancer. Front. Immunol. 15:1412328 .  \ndoi: 10.3389/fimmu.2024.1412328  \nCOPYRIGHT  \n© 2024 Chen, Yang, Ma and Zhang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nRecent advances in understanding the immune microenvironment in ovarian cancer  \nJinxin Chen 1, Lu Yang 2, Yiming Ma 3,4* and Ye Zhang 5*  \n1 Department of Gynecology, Cancer Hospital of Dalian University of Technology, Cancer Hospital of China Medical University, Liaoning Cancer Hospital & Institute, Shenyang, China, 2 Department of Internal Medicine, Cancer Hospital of Dalian University of Technology, Cancer Hospital of China Medical University, Liaoning Cancer Hospital & Institute, Shenyang, China, 3 Department of Medical Oncology, Liaoning Cancer Hospital & Institute, Shenyang, Liaoning, China, 4 Liaoning Key Laboratory of Gastrointestinal Cancer Translational Research, Shenyang, Liaoning, China, 5 Department of Radiation Oncology, Cancer Hospital of Dalian University of Technology, Cancer Hospital of China Medical University, Liaoning Cancer Hospital & Institute, Shenyang, China  \nThe occurrence of ovarian cancer (OC) is a major factor in women’s mortality rates. Despite progress in medical treatments, like new drugs targeting homologous recombination deﬁciency, survival rates for OC patients are still not ideal. The tumor microenvironment (TME) includes cancer cells, ﬁbroblasts linked to cancer (CAFs), immune-inﬂammatory cells, and the substances these cells secrete, along with non-cellular components in the extracellular matrix (ECM) . First, the TME mainly plays a role in inhibiting tumor growth and protecting normal cell survival. As tumors progress, the TME gradually becomes a place to promote tumor cell progression. Immune cells in the TME have attracted much attention as targets for immunotherapy. Immune checkpoint inhibitor (ICI) therapy has the potential to regulate the TME, suppressing factors that facilitate tumor advancement, reactivating immune cells, managing tumor growth, and extending the survival of patients with advanced cancer. This review presents an outline of current studies on the distinct cellular elements within the OC TME, detailing their main functions and possible signaling pathways. Additionally, we examine immunotherapy rechallenge in OC, with aspeciﬁc emphasis on the biological reasons behind resistance to ICIs.  \nKEYWORDS  \novarian cancer, tumor environment, immune cells, immune checkpoint inhibitor, immunotherapy  \nFrontiers in Immunology 01 [frontiersin.org](frontiersin.org)  \n1 Introduction  \nOvarian cancer (OC) is a prevalent form of gynecological cancer, recognized for its aggressive nature and tendency to metastasize (1). Its atypical presentation poses challenges for early detection and treatment, with approximately three-quarters of OC cases diagnosed at an advanced stage (2). OC includes various types, including epithelial tumors","cbCaibMdRgYXyr1p","https://ap.wps.com/l/cbCaibMdRgYXyr1p","pdf",4137803,28,"English","# Introduction\n## Ovarian cancer overview and subtypes\n# Tumor microenvironment and immune regulation\n## Immune checkpoint inhibitor therapy and TME modulation\n# Cellular elements and signaling pathways\n# Immunotherapy rechallenge and resistance","[{\"question\":\"Why is the immune microenvironment important in ovarian cancer?\",\"answer\":\"The tumor microenvironment can initially suppress tumor growth but later shifts to promote tumor progression. Immune cells within this microenvironment are therefore key targets for immunotherapy.\"},{\"question\":\"How does immune checkpoint inhibitor therapy relate to the tumor microenvironment?\",\"answer\":\"Immune checkpoint inhibitors have the potential to regulate the tumor microenvironment by suppressing pro-tumor factors, reactivating immune cells, managing tumor growth, and extending survival in advanced cancer.\"},{\"question\":\"What does the review cover regarding immunotherapy rechallenge?\",\"answer\":\"The review examines immunotherapy rechallenge in ovarian cancer, with emphasis on the biological reasons underlying resistance to immune checkpoint inhibitors.\"}]","Recent advances in understanding the immune microenvironment in ovarian cancer - Review | PDF",1790041597,71,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ebad24ce473d569e4896ded1c0c8ce34.webp",983,1389,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5c581fe1053cd959ecec13dd8c03209d.webp",982,1388,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/52cd9b482d24e5c5a9875f475171ccff.webp",981,1386,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/097ead0849e957946c88af58106146c3.webp",980,1385]